Lastly, results from the CPTAC dataset showed that FCGR3A total protein expression was higher in primary tissues of breast cancer, clear cell renal cell carcinoma, colon cancer, head and neck squamous cell carcinoma, ovarian cancer, pancreatic adenocarcinoma, and uterine corpus endometrial carcinoma than in normal tissues. Here, FCGR3A is linked to breast cancer.